GlassScriptPhysician profile
Sylvia H Hoang
NPI 1760549109
$1,197.23
in general payments reported to CMS, 2019-2025
25 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $47.44 · 2021: $69.23 · 2022: $171 · 2023: $162 · 2024: $32.87 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.57 | 2019-2023 | Andexxa, Farxiga |
| Janssen Pharmaceuticals, INC | $124.86 | 2019-2024 | Xarelto |
| Pfizer INC. | $122.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.93 | 2019-2022 | |
| Exact Sciences Corporation | $80.64 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $76.55 | 2022 | |
| Akcea Therapeutics, INC. | $55.21 | 2019 | |
| Glaxosmithkline, LLC. | $51.36 | 2023 | Shingrix, Arexvy |
| Novo Nordisk INC | $49.54 | 2019-2025 | Ozempic |
| Amgen INC. | $40.44 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $34.78 | 2022 | |
| Neurocrine Biosciences, INC. | $34.27 | 2025 | |
| Astellas Pharma US INC | $33.29 | 2023 | Veozah |
| Boston Scientific Corporation | $27.73 | 2021-2023 | Watchman Flx |
| Merck Sharp & Dohme LLC | $23.69 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $23.32 | 2022 | |
| Abbott Laboratories | $22.98 | 2023 | Gallant |
| Sanofi-Aventis U.S. LLC | $20.11 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.39 | 2021 | |
| Genentech USA, INC. | $19.00 | 2019 | |
| Fresenius Kabi USA, LLC | $17.87 | 2024 | Idacio |
| Hikma Pharmaceuticals USA | $17.19 | 2019 | |
| Edwards Lifesciences Corporation | $17.15 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teva Pharmaceuticals USA, INC. | $15.75 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.